Repair Pathway Choices and Consequences at the Double-Strand Break

Overview

Journal Trends Cell Biol

Specialty Cell Biology

Date 2015 Oct 7

PMID 26437586

Citations 772

Authors

Raphael Ceccaldi

Beatrice Rondinelli

Alan D DAndrea

Affiliations

Soon will be listed here.

Abstract

DNA double-strand breaks (DSBs) are cytotoxic lesions that threaten genomic integrity. Failure to repair a DSB has deleterious consequences, including genomic instability and cell death. Indeed, misrepair of DSBs can lead to inappropriate end-joining events, which commonly underlie oncogenic transformation due to chromosomal translocations. Typically, cells employ two main mechanisms to repair DSBs: homologous recombination (HR) and classical nonhomologous end joining (C-NHEJ). In addition, alternative error-prone DSB repair pathways, namely alternative end joining (alt-EJ) and single-strand annealing (SSA), have been recently shown to operate in many different conditions and to contribute to genome rearrangements and oncogenic transformation. Here, we review the mechanisms regulating DSB repair pathway choice, together with the potential interconnections between HR and the annealing-dependent error-prone DSB repair pathways.

Citing Articles

Lipoylation inhibition enhances radiation control of lung cancer by suppressing homologous recombination DNA damage repair.

Chiang J, Shang Z, Rosales T, Cai L, Chen W, Cai F Sci Adv. 2025; 11(11):eadt1241.

PMID: 40073141 PMC: 11900879. DOI: 10.1126/sciadv.adt1241.

Molecular breeding of pigs in the genome editing era.

Chen J, Wang J, Zhao H, Tan X, Yan S, Zhang H Genet Sel Evol. 2025; 57(1):12.

PMID: 40065264 PMC: 11892312. DOI: 10.1186/s12711-025-00961-7.

Harnessing transcriptional regulation of alternative end-joining to predict cancer treatment.

Espin R, Medina-Jover F, Siguenza-Andrade J, Farran-Matas S, Mateo F, Figueras A NAR Cancer. 2025; 7(1):zcaf007.

PMID: 40061566 PMC: 11886861. DOI: 10.1093/narcan/zcaf007.

Prospects and challenges of ovarian cancer organoids in chemotherapy research (Review).

Zhang W, Ding Y, He H, Chen K, Zeng Q, Cao X Oncol Lett. 2025; 29(4):198.

PMID: 40052067 PMC: 11883337. DOI: 10.3892/ol.2025.14944.

The Landscape of PARP Inhibitors in Solid Cancers.

Muzzana M, Broggini M, Damia G Onco Targets Ther. 2025; 18:297-317.

PMID: 40051775 PMC: 11884256. DOI: 10.2147/OTT.S499226.

References

Schwendener S, Raynard S, Paliwal S, Cheng A, Kanagaraj R, Shevelev I . Physical interaction of RECQ5 helicase with RAD51 facilitates its anti-recombinase activity. J Biol Chem. 2010; 285(21):15739-45. PMC: 2871440. DOI: 10.1074/jbc.M110.110478. View

Lord C, Tutt A, Ashworth A . Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors. Annu Rev Med. 2014; 66:455-70. DOI: 10.1146/annurev-med-050913-022545. View

Hu Y, Petit S, Ficarro S, Toomire K, Xie A, Lim E . PARP1-driven poly-ADP-ribosylation regulates BRCA1 function in homologous recombination-mediated DNA repair. Cancer Discov. 2014; 4(12):1430-47. PMC: 4258125. DOI: 10.1158/2159-8290.CD-13-0891. View

Watkins J, Weekes D, Shah V, Gazinska P, Joshi S, Sidhu B . Genomic Complexity Profiling Reveals That HORMAD1 Overexpression Contributes to Homologous Recombination Deficiency in Triple-Negative Breast Cancers. Cancer Discov. 2015; 5(5):488-505. PMC: 4490184. DOI: 10.1158/2159-8290.CD-14-1092. View

Barber L, Youds J, Ward J, McIlwraith M, ONeil N, Petalcorin M . RTEL1 maintains genomic stability by suppressing homologous recombination. Cell. 2008; 135(2):261-71. PMC: 3726190. DOI: 10.1016/j.cell.2008.08.016. View

Kent T, Chandramouly G, McDevitt S, Ozdemir A, Pomerantz R . Mechanism of microhomology-mediated end-joining promoted by human DNA polymerase θ. Nat Struct Mol Biol. 2015; 22(3):230-7. PMC: 4351179. DOI: 10.1038/nsmb.2961. View

Liang C, Zhan B, Yoshikawa Y, Haas W, Gygi S, Cohn M . UHRF1 is a sensor for DNA interstrand crosslinks and recruits FANCD2 to initiate the Fanconi anemia pathway. Cell Rep. 2015; 10(12):1947-56. PMC: 4386029. DOI: 10.1016/j.celrep.2015.02.053. View

Treuner K, Helton R, Barlow C . Loss of Rad52 partially rescues tumorigenesis and T-cell maturation in Atm-deficient mice. Oncogene. 2004; 23(27):4655-61. DOI: 10.1038/sj.onc.1207604. View

Sarangi P, Steinacher R, Altmannova V, Fu Q, Paull T, Krejci L . Sumoylation influences DNA break repair partly by increasing the solubility of a conserved end resection protein. PLoS Genet. 2015; 11(1):e1004899. PMC: 4287433. DOI: 10.1371/journal.pgen.1004899. View

10.

Wu Y, Kantake N, Sugiyama T, Kowalczykowski S . Rad51 protein controls Rad52-mediated DNA annealing. J Biol Chem. 2008; 283(21):14883-92. PMC: 2386943. DOI: 10.1074/jbc.M801097200. View

11.

Popova T, Manie E, Rieunier G, Caux-Moncoutier V, Tirapo C, Dubois T . Ploidy and large-scale genomic instability consistently identify basal-like breast carcinomas with BRCA1/2 inactivation. Cancer Res. 2012; 72(21):5454-62. DOI: 10.1158/0008-5472.CAN-12-1470. View

12.

Aparicio T, Baer R, Gautier J . DNA double-strand break repair pathway choice and cancer. DNA Repair (Amst). 2014; 19:169-75. PMC: 4051845. DOI: 10.1016/j.dnarep.2014.03.014. View

13.

Paliwal S, Kanagaraj R, Sturzenegger A, Burdova K, Janscak P . Human RECQ5 helicase promotes repair of DNA double-strand breaks by synthesis-dependent strand annealing. Nucleic Acids Res. 2013; 42(4):2380-90. PMC: 3936725. DOI: 10.1093/nar/gkt1263. View

14.

Bennardo N, Cheng A, Huang N, Stark J . Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008; 4(6):e1000110. PMC: 2430616. DOI: 10.1371/journal.pgen.1000110. View

15.

Yousefzadeh M, Wood R . DNA polymerase POLQ and cellular defense against DNA damage. DNA Repair (Amst). 2012; 12(1):1-9. PMC: 3534860. DOI: 10.1016/j.dnarep.2012.10.004. View

16.

Sommers J, Rawtani N, Gupta R, Bugreev D, Mazin A, Cantor S . FANCJ uses its motor ATPase to destabilize protein-DNA complexes, unwind triplexes, and inhibit RAD51 strand exchange. J Biol Chem. 2009; 284(12):7505-17. PMC: 2658046. DOI: 10.1074/jbc.M809019200. View

17.

Polato F, Callen E, Wong N, Faryabi R, Bunting S, Chen H . CtIP-mediated resection is essential for viability and can operate independently of BRCA1. J Exp Med. 2014; 211(6):1027-36. PMC: 4042650. DOI: 10.1084/jem.20131939. View

18.

Bakr A, Oing C, Kocher S, Borgmann K, Dornreiter I, Petersen C . Involvement of ATM in homologous recombination after end resection and RAD51 nucleofilament formation. Nucleic Acids Res. 2015; 43(6):3154-66. PMC: 4381069. DOI: 10.1093/nar/gkv160. View

19.

Yun M, Hiom K . CtIP-BRCA1 modulates the choice of DNA double-strand-break repair pathway throughout the cell cycle. Nature. 2009; 459(7245):460-3. PMC: 2857324. DOI: 10.1038/nature07955. View

20.

Kim T, Son M, Dodds S, Hu L, Luo G, Hasty P . RECQL5 and BLM exhibit divergent functions in cells defective for the Fanconi anemia pathway. Nucleic Acids Res. 2014; 43(2):893-903. PMC: 4333386. DOI: 10.1093/nar/gku1334. View